Methylphenidate (MPH) remains an important therapy for attention-deficit hyperactivity disorder, but aspects of its pharmacology remain unclear. In the present study, we used a regimen of MPH (8 mg/kg daily × 14 days) in C57BL/6J mice to determine whether establishing locomotor sensitization to MPH influenced the acquisition and the dose-response function of MPH in a classic drug discrimination procedure. MPH-sensitized mice (SENS group) showed enhanced locomotor activity to the 8 mg/kg exposure dose as well as a 2 mg/kg dose before discrimination training. However, the SENS mice did not acquire discrimination of either a low dose (2 mg/kg) or a higher dose (4 mg/kg) of MPH any more rapidly than the CTRL mice. Further, during generalization testing, the dose-response functions for the SENS and CTRL mice were identical. Therefore, we did not find that previous exposure to MPH, which produced a sensitized locomotor response, facilitated MPH discrimination. Behavioural Pharmacology 25:766-774
Introduction
Methylphenidate (MPH) continues to be an important pharmacotherapeutic option for the treatment of attentiondeficit hyperactivity disorder (Biederman and Spencer, 2002; Biederman and Faraone, 2005) . Unfortunately, individuals also divert MPH to nonmedical uses (Kroutil et al., 2006; Darredeau et al., 2007; Novak et al., 2007) , especially by high school (McCabe et al., 2004) and college (Teter et al., 2003; McCabe et al., 2006; Godfrey, 2009) students. Concern in terms of prescription drug abuse in general, and MPH in particular, has prompted the continued study of MPH in humans and rodents under a variety of situations and conditions (e.g. Patrick et al., 2007; Bell et al., 2011; Brookshire and Jones, 2012; Griffin et al., 2013; Hammerness et al., 2013; Jones and Dafny, 2013) . Moreover, recent reports indicate that despite behavioral effects similar to psychostimulants such as cocaine, MPH exerts distinct effects on monoaminergic transmission, which appear to be unique among the variety of drugs that target the dopamine transporter (Calipari et al., 2014; Ferris et al., 2012) . Therefore, there is still a great deal to learn about this drug that has been in widespread clinical use for many decades.
In humans, MPH produces positive subjective effects (Kollins et al., 2001 (Kollins et al., , 2009 Heil et al., 2002; Stoops et al., 2005a; Patrick et al., 2007) , which may serve as discriminative stimuli. Direct evidence that MPH produces a discriminative stimulus comes from several drug discrimination studies in humans (Stoops et al., 2005b; Lile et al., 2006; Duke et al., 2011) , rats (Overton and Shen, 1988; Perkins et al., 1991) , and mice (McGovern et al., 2011; Griffin et al., 2013) . A number of reports also describe the ability of MPH to at least partially substitute for other psychostimulants such as cocaine (Bondareva et al., 2002; Rush et al., 2002; Schweri et al., 2002; Li et al., 2006) , amphetamine (Bondareva et al., 2002; Czoty et al., 2004) , and methamphetamine (Sevak et al., 2009; Desai et al., 2010) .
It has been appreciated for many years that previous experience with a psychoactive drug can influence subsequent responses to that drug, indicating that the underlying neurobiology has been adapted because of the previous exposure. Depending on the circumstances, the adapted response can be characterized as either tolerance or sensitization (Becker et al., 2013) . Sensitization may be the most commonly studied neuroadaptation for psychostimulants because it appears to play an important role in addiction Berridge, 1993, 2001; Leyton, 2007; Vezina and Leyton, 2009 ). In experimental settings, psychostimulant sensitization is commonly shown as increased locomotor activity following repeated exposures to the drug. Several reports indicate that repeated exposure to MPH induces locomotor sensitization in rodents (Askenasy et al., 2007; Yang et al., 2007 Yang et al., , 2011 .
With operant drug discrimination tasks, the influence of previous drug experience on discriminability has been most commonly studied with respect to effects of the training dose on the discriminative stimulus response function, and a comprehensive review has been published recently (Stolerman et al., 2011) . Although there are exceptions, higher training doses generally lead to faster acquisition of the discriminative behavior compared with lower training doses, and discriminative stimulus response functions are shifted rightward with higher doses (Stolerman et al., 2011) . Interestingly, early work with LSD found that establishing discrimination with 80 μg/kg and then substituting a lower dose (10 μg/kg) during training sessions significantly improved discriminability of the lower dose during subsequent testing compared with tests conducted before the substitution (83 vs. 30% responding, respectively, on the drug-paired lever) (Greenberg et al., 1975) . These findings are consistent with the development of sensitization to the discriminative stimulus effects of the drug.
In contrast, the impact of drug exposure outside the context of the discrimination task has been studied less commonly, although examples can be found. For example, exposure outside of the training context produces tolerance to the ethanol discriminative stimulus Crissman et al., 2004) and the morphine discriminative stimulus (Sannerud and Young, 1987; Young et al., 1996) . An early study showed that pre-exposure to scopolamine reduced the time to acquire discrimination in an avoidance task but, interestingly, produced a rightward shift in the generalization function (McKim, 1976) . Finally, it was reported that pre-exposure to the psychostimulant methamphetamine produced a significant leftward shift in the discriminative stimulus response function for methamphetamine, indicating that low doses were more easily discriminated when rats were pre-exposed to the psychostimulant (Suzuki et al., 2004) . Further, despite the leftward shift in the stimulus response function, no differences were noted on the acquisition of the discrimination task with the methamphetamine pre-exposure (Suzuki et al., 2004) . These studies indicate that drug exposure separate from the training context can influence the discriminative stimulus control of reinforced behavior, although the effects may vary by drug and exposure procedure.
Our previous study showed that mice could readily learn to discriminate doses of MPH equal to or greater than 4 mg/kg, but not lower doses (McGovern et al., 2011) . Interestingly, although low doses of MPH (< 5 mg/kg) do not overtly increase locomotion (Williard et al., 2007; Griffin et al., 2010 Griffin et al., , 2013 , low doses can support the development of place preference and reduce ethanol consumption (Griffin et al., 2010) . In addition, these low doses interact pharmacologically with ethanol to augment locomotion and discrimination (Griffin et al., 2010 . Work from other laboratories indicates that MPH (< 5 mg/kg) produces significant changes in monoamine concentrations (Kuczenski and Segal, 1997; Berridge et al., 2006; Balcioglu et al., 2009; Koda et al., 2010) . Collectively, these studies indicate that low doses of MPH are pharmacologically active, and it is possible that previous exposure to MPH may influence the acquisition of behaviors dependent on the recognition of the discriminative stimulus effects of MPH. In the present study, we hypothesized that pre-exposure to a locomotor-sensitizing regimen of MPH would enhance discrimination of low doses of MPH.
Methods

Subjects
C57BL/6J mice (n = 20) were obtained from Jackson Laboratories (Bar Harbor, Maine, USA) at 7 weeks of age. Animals were singly housed on a 12-h reverse light cycle (lights on at 20:00 h, lights off at 08:00 h), with free access to water, and allowed to acclimate to home cages for ∼ 2 weeks before behavioral testing. Following this acclimation period, mice were maintained at 85-90% of their free feeding body weight, except as noted below during the sensitization procedure. These experiments were approved by the Institutional Animal Care and Use Committee at the Medical University of South Carolina and were conducted according to the NIH Guide for the Care and Use of Laboratory Animals (NIH Publication No. 80-23, Revised 1996) .
Locomotor activity apparatus
Locomotor activity was assessed using a Digiscan Animal Activity Monitor system, model RXYZCM(8) TAO (Accuscan Instruments, Columbus, Ohio, USA), which has been described in several publications (Griffin and Middaugh, 2006; Griffin et al., 2010 Griffin et al., , 2012 Griffin et al., , 2013 .
Drug discrimination apparatus
Drug discrimination was assessed in operant chambers controlled by MedPC software that were enclosed in sound-attenuating and light-attenuating cabinets (MedAssociates Inc., St Albans, Vermont, USA) as described in several drug discrimination studies (McGovern et al., 2011; Griffin et al., 2012 Griffin et al., , 2013 . In this study, behavior was reinforced with a 5 s presentation of 0.01 ml of a 15% sucrose solution by a dipper located between two levers in each chamber. The MPH reinforced lever (right or left) was counterbalanced across the subjects in both groups.
Sensitization induction and testing procedures
After mice were trained to press levers for sucrose reinforcement (see below), the sensitization regimen began, with group assignment counterbalanced for lever pressing rate during the final session of training. During this phase, mice resumed ad libitum feeding. Mice were treated once daily with either 8 mg/kg MPH (SENS group) or vehicle (CTRL group) for 14 days. This dose is near maximal for increasing locomotor activity in mice (Williard et al., 2007) . MPH injections were administered and the mice were returned to their home cage; however, on day 1, day 8, and day 14, mice were immediately placed into the locomotor activity monitor for 60 min. Following a 2-day washout period with no treatments provided, mice were again challenged with MPH (2 mg/kg) or vehicle in the locomotor activity monitor (60 min sessions). For this rechallenge, all mice were treated with both MPH and vehicle using a Latin-square design over a 2-day period. Mice resumed drug discrimination training after a 2-week washout period.
Drug discrimination procedures
The procedures used for MPH discrimination have been described previously . Briefly, to establish responding for the sucrose reinforcement, a shaping procedure began with an FR1 schedule (e.g. 1 lever press per reinforcer) that increased gradually over sessions to reach a final schedule of FR15, which was used for the rest of the study. After training, mice entered the sensitization induction and testing phase of the study (described above) before resuming discrimination training, beginning first with 2 mg/kg MPH and then increasing to 4 mg/kg. For this study, 15 min sessions occurred once per day, with injections administered 15 min before the session. MPH or vehicle was administered according to a semirandomized schedule that ensured no more than 2 consecutive days of MPH or vehicle and an equal number of exposures to each over a 2-week period. For successful discrimination, the first criterion was that mice make at least 80% of responses on the injection-appropriate lever before the first reinforcement [called first fixed ratio (FFR)] over at least three consecutive sessions. In addition, mice were required to make at least 85% of total responses on the injectionappropriate lever during three consecutive sessions. On fulfillment of these criteria, mice were eligible for MPH discrimination testing. Discrimination tests lasted 2 min and were conducted under extinction conditions. All other procedures were the same as during the training sessions. After every generalization test, mice resumed training and were required to fulfill the discrimination criteria during at least three consecutive training sessions before another discrimination test session was conducted. For the dose substitution curves, mice were tested in ascending order of doses and twice at each dose, with the exception that MPH doses greater than the training doses were tested only once.
Drugs
MPH·HCl (Sigma-Aldrich Inc., St Louis, Missouri, USA) was used as the racemic mixture (i.e. DL-MPH) by dissolution in 0.9% saline and administered intraperitoneally in a volume of 0.01 ml/g body weight.
Data analysis
Comparison of group means was carried out using Student's t-test and between-group comparisons with multiple groups were carried out using analysis of variance (ANOVA), with repeated-measures (RM) as appropriate. Post-hoc analysis was carried out using Bonferroni's corrected pairwise comparisons. Evaluation of counted data was carried out using χ 2 analysis. For all analyses, significance levels were set at P less than 0.05.
Results
Induction of locomotor sensitization by methylphenidate
After all the mice were trained to press a lever for sucrose reinforcement, the sensitization phase of the study began. These results are summarized in Fig. 1 . As can be seen, in the CTRL group, the dose of MPH used for the induction of locomotor sensitization (8 mg/kg) produced a large increase in the distance traveled in the SENS group compared with vehicle (0 mg/kg). During the third session, the SENS group showed a slight increase in the total distance traveled compared with previous sessions. These observations were supported by a 2(Group) × 3 (Session) × 6(Time) RM ANOVA where session and time within session were treated as within-subjects RM. The three-way interaction was significant [F(10,180) = 11.17, P < 0.001] as were all three possible two-way interactions (all F's > 5 and all P's < 0.01).
The data were further analyzed using two-way ANOVAs within groups. Within the SENS group, the 3(Session) × 6 (Time) RM ANOVA detected a significant interaction [F(10,90) = 10.99, P < 0.001). Post-hoc analysis of these data indicated that, within the SENS group, the distance traveled during test 3 was greater than during Session 2 (P = 0.018). However, the same analysis of the data from the CTRL group did not show a significant interaction [F(10,90) = 1.71, P = 0.09], although it did detect significant main effects of Session [F(2,18) = 5.736, P < 0.02) and Time [F(5,45) = 86, P < 0.001]. Together, these analyses indicate that locomotor activity increased significantly as a function of repeated exposure to 8 mg/kg of MPH, indicating sensitization to the locomotoractivating effects of MPH.
Challenge with 2 mg/kg methylphenidate Following the induction phase, all mice were challenged with 0 and 2 mg/kg MPH using a Latin-square design. The data from this experiment are summarized in Fig. 2 . The data show that MPH at a dose one-quarter of that used in the previous phase of the study still increased the distance traveled above that of the vehicle challenge. In the CTRL group, there was only a slight overall increase compared with the vehicle, whereas the increase in the distance traveled for the SENS group was greater. These data were analyzed using a 2(Group) × 2(Dose) The three-way interaction was further evaluated according to Time using separate 2(Group) × 2(Dose) ANOVAs, where the Dose factor served as a RM during each time bin. The analysis of data from the first time bin detected a significant interaction [F(1,18) = 6.58, P < 0.02]. Posthoc analysis found that the SENS group traveled further after the 2 mg/kg challenge than after vehicle challenge (P < 0.001) as well as traveling a greater distance than the CTRL mice challenged with 2 mg/kg (P < 0.01). Within the CTRL group, MPH-treated mice did not increase the distance traveled more than those treated with vehicle (P > 0.2) at the first time point. At the second time point (i.e. the 20 min bin), the Group × Dose interaction approached significance [F(1,18) = 3.294, P = 0.086], but the Group factor was not significant [F(1,18) = 1.73, NS]. At this time point, only the effect of Dose was significant [F(1,18) = 22, P < 0.001]. For the remaining RM ANOVAs carried out for time points 3-6, only the Dose effect remained significant (all F's > 4), but none of the Group effects or interactions were significant (all F's < 1.5, NS). These analyses indicate that mice in the SENS group responded more to the low challenge dose of 2 mg/kg MPH than the CTRL group. The results of this challenge experiment further support the previous observation that repeated exposure to MPH produced locomotor sensitization in the SENS group.
Methylphenidate discrimination
Following the sensitization procedure, mice resumed discrimination training. Initially, mice began training to discriminate 2 mg/kg MPH from vehicle. After 29 sessions of this procedure, the active dose was changed to 4 mg/kg MPH for an additional 20 sessions of acquisition training. Consistent with our previous work (McGovern et al., 2011) , the 2 mg/kg MPH dose did not engender reliable discrimination in either group during this evaluation period, but once the dose was increased to 4 mg/kg, the mice did show reliable discrimination.
Responding for the 2 and 4 mg/kg MPH doses is summarized in , respectively, for all of the training sessions. The data in Fig. 3a and b show that, in general, the two groups of mice responded similarly across the training sessions on the injection-paired lever (IPL; either for vehicle or 2 mg/kg of MPH) in terms of percent total responding on the IPL or for completing the FFR. Overall, the ability of the mice to discriminate the MPH injection from the vehicle injection increased with time, but still did not consistently fulfill the criteria irrespective of MPH exposure history. These observations were supported by a 2(Group) × 29(Session) ANOVA on the % IPL data, with Session as a RM, and no significant interaction was found [F(28,504) = 1.24, NS], only a significant main effect of time [F(28,504) = 5.21, P < 0.001], consistent with the overall increase in %IPL as the sessions progressed. After the training dose was increased to 4 mg/kg, both groups of mice began responding consistently at criterion performance levels and, again, no influence of previous sensitization emerged for IPL responding ( Fig. 4a and b) . These data were similarly analyzed as for the lower dose and only a significant main effect of Session was noted [F(28,504) = 2.77, P < 0.001], with no significant interaction [F(28,504) = 1.48, NS]. Collectively, these data do not support the hypothesis that previous experience with MPH enhanced the acquisition of discriminative stimulus control of reinforced behavior.
Further examination of the data confirmed our initial evaluation: when maintained on the 2 mg/kg training regimen, the SENS mice performed slightly better with respect to FFR responding (69 vs. 61%) and total percent responding on the IPL (80 vs. 72%) when compared with the CTRL mice. The data shown in Fig. 3c are averaged from the last 3 days of training with 2 mg/kg MPH. Student's t-tests on these data did not detect significant differences between CTRL and SENS mice [both t's < 1.3, d.f. = 18, NS] for the 2 mg/kg dose. Further, it is clear that once the training dose was increased to 4 mg/kg, mice in both groups readily discriminated the active MPH dose from vehicle, easily fulfilling the criteria for advancing to the discrimination testing phase (Fig. 4c ). Student's t-tests on the 4 mg/kg FFR and total percent response data did not detect differences between CTRL and SENS mice (both t's < 1.3, d.f. = 18, NS). These analyses using the traditional measures for acquisition of discrimination (FFR and percent responding on the drug-paired lever) indicate that the 2 mg/kg training dose was inadequate for supporting MPH discrimination compared with the 4 mg/kg dose. Finally, we investigated the performance of the two groups of mice by counting the number of sessions in which mice in either group fulfilled the criteria for discrimination testing and the number of mice fulfilling criteria. These data came from the last 3 days of training on either the 2 or the 4 mg/kg doses and are summarized in Figs 3d and 4d . The total number of sessions in which mice could fulfill the criteria for discrimination testing was 30 per group across vehicle and MPH training sessions (n = 10 mice for three sessions each). Interestingly, for the 2 mg/kg data, we found that, as a group, the SENS mice had nearly double the number of sessions in which the mice fulfilled criteria (17/30 sessions) compared with the CTRL group (9/30 sessions). χ 2 analysis on these data was significant (χ 2 = 4.34, d.f. = 1, P < 0.05). However, the same analysis for the analogous data with the 4 mg/kg training dose indicated no difference between CTRL (27/30 sessions) and SENS (23/30 sessions) groups (χ 2 = 1.92, d.f. = 1, NS). In addition, when the numbers of mice were counted that consistently fulfilled the criteria to be tested over each of the last three sessions for the 2 mg/kg dose, the CTRL group had zero mice and the SENS group had two mice. At the end of the 4 mg/kg training period, both groups had seven mice consistently fulfilling the criterion levels of responding. χ 2 analysis on these data did not detect differences at either dose (both χ 2 < 2.2, d.f. = 1, NS). Although, as a group, the SENS mice had more sessions fulfilling the performance criteria while training with 2 mg/kg MPH, this was largely because of only two out of the 10 mice in this group consistently fulfilling the criteria for successful discrimination at the low dose.
Methylphenidate discrimination testing
At the conclusion of the acquisition phase, discrimination testing proceeded. Interestingly, two mice in the SENS group never fulfilled the criteria for testing at any time and were excluded from further analysis. In addition, two mice in the CTRL group were excluded from further analysis because their response rates decreased to very low levels once discrimination testing began. Note that these four mice were included in all analyses described above, but are excluded from the analyses described below. Therefore, for the discrimination phase of the study, the group sizes were n is equal to 8 for both the CTRL and the SENS groups. These data are summarized in Fig. 5 . During testing, mice of both groups showed dose-dependent discrimination of MPH. However, no differences were noted between the groups. A 2(Group) × 5(Dose) RM ANOVA found only a significant effect of Dose [F(3,42) = 13.52, P < 0.001], but neither the main effect of Group nor the Dose × Group interaction was significant (both F's < 1, NS). Total responses were analyzed in the same way and, again, there was only a significant main effect of Group, consistent with the lower responding for the 1 and 2 mg/kg doses [F(3,42) = 5.80, P < 0.002]. For total responses, there were no significant effects of Group and no significant interaction (both F's < 1, NS).
A higher dose of MPH (6 mg/kg) was also tested once in each mouse. The total average responses were 99 12 and 126 15 for CTRL and SENS mice, respectively. The 6 mg/kg dose, however, generated most of this responding on the vehicle-paired lever as the percent responding on the drug-paired lever was only 4.93 1.83 and 11.2 4.61% for CTRL and SENS mice, respectively. Student's t-tests on both of these data sets did not detect any differences (t < 1.2, d.f. = 14, NS).
Discussion
We found that daily exposure to 8 mg/kg MPH produced locomotor sensitization in B6 mice, consistent with other published work (Askenasy et al., 2007) . Sensitization was also evident when the mice were rechallenged with a low dose of MPH (2 mg/kg), the same dose subsequently used for initial training in the operant discrimination task, indicating that a dose that would ordinarily not increase activity had acquired new pharmacological relevance. However, this did not translate into more rapid acquisition of the discrimination behavior when the training dose was 2 mg/kg MPH. When the MPH dose was increased to 4 mg/kg, most of the mice in both groups ultimately acquired discrimination behavior, with no discernible differences in acquisition or in the discriminative stimulus response function. These results are interesting because they are counter to the expectation that previous experience with a drug should influence the acquisition or dose-response function for discrimination tasks.
Although numerous studies have shown that higher doses within the training context lead to more rapid acquisition of drug discrimination behavior (Stolerman et al., 2011) , at least one report indicates that previous exposure to a drug (scopolamine) before training reduces time to acquisition (McKim, 1976) . However, the present results indicate that significant experience with high doses of MPH outside of training does not influence acquisition of MPH discrimination with a low dose. In support of the current findings, it is noteworthy that Suzuki et al. (2004) did not report any differences in acquisition in their study with methamphetamine.
However, some studies indicate the possibility that drug exposure outside of the training context influences the generalization curve after reliable discrimination is established. For instance, some studies have reported that once mice are trained in the discrimination task, drug exposure outside of the training context shifts the generalization curve to the right (Sannerud and Young, 1987; Young et al., 1996; Becker et al., 2004; Crissman et al., 2004) , indicative of tolerance. Germane to the present study, two previous reports found that exposing subjects to the drug before discrimination training could shift the discriminative stimulus response function either to the right (McKim, 1976) or to the left (Suzuki et al., 2004) . However, our data do not indicate that any shift occurred as a result of significant previous exposure to MPH.
Interest in low doses of MPH (e.g. 3 mg/kg or less) in behavioral pharmacology experiments is driven by clinical significance. Relatively low doses of MPH are used therapeutically in humans to treat ADHD (Kuczenski and Segal, 2005) and can interact significantly with ethanol in humans and in rodent models (Griffin et al., 2010 . Further, evidence indicates that low doses of MPH not only affect behavior but also increase extracellular levels of dopamine and norepinephrine in rodents in a regionally specific manner Segal, 1997, 2001; Berridge et al., 2006; Balcioglu et al., 2009; Koda et al., 2010) .
The dissociation between significant pharmacological effects of low doses of MPH (e.g. 3 mg/kg or less) on some behaviors and the inability of these same doses to support acquisition of a classic drug discrimination task is interesting. Because MPH is used at relatively low doses in humans to improve attention (Biederman and Spencer, 2002) and improves the performance of rodents in cognitive tasks (Berridge et al., 2006) , it might be expected that the mice (whether sensitized or not) should be able to learn a challenging discrimination task quickly with a low dose (e.g. 2 mg/kg). However, this is not the case with the discrimination task that we used. Evidence suggests that differential effects on monoamine transmission within cortical and subcortical regions could offer an explanation for this discrepancy. Reports indicate that low doses of MPH significantly increase extracellular dopamine and norepinephrine in the mouse and rat prefrontal cortex and, in contrast, cause relatively little change in striatal areas, even with repeated exposure (Berridge et al., 2006; Koda et al., 2010) . Behaviorally, there is evidence from lesion studies that the prefrontal cortex is involved in the development of locomotor sensitization to MPH (Lee et al., 2008) and in discrimination tasks for alcohol (Hodge and Cox, 1998) and nicotine (Smith and Stolerman, 2009) . Similarly, striatal regions have also been shown to be important for the discriminative stimulus control of reinforced behavior by alcohol (Hodge and Alken, 1996; Hodge and Cox, 1998; Besheer et al., 2003) . As low doses of MPH preferentially increase monoamines in frontal cortical areas but low doses are not associated with the acquisition of our discrimination task (present study and McGovern et al., 2011), it appears that significantly increasing extracellular monoamine levels in the prefrontal cortex may not be sufficient to drive acquisition of the discriminative stimulus control of behavior by MPH, even in sensitized mice. Thus, for the discriminative stimulus of MPH to gain control of reinforced behavior, the engagement of striatal areas that occurs at higher MPH doses (Koda et al., 2010) may be necessary. Of course, further testing is required to confirm this hypothesis.
There are some issues that deserve consideration in relation to the present studies. First, an argument can be made that training sessions should have simply continued using the 2 mg/kg training dose until mice showed reliable discrimination. However, at the end of our training period with the low dose, mice in both groups were performing similarly. Thus, there was no strong evidence that sensitization to MPH influenced acquisition of the discrimination task to the low dose. Further, Suzuki et al. (2004) suggested that a leftward shift in the generalization curve for a psychostimulant could occur without apparent effects on acquisition. Therefore, we increased the training dose so that we could conduct generalization testing with mice reliably fulfilling the discrimination criteria. Another consideration is that the pharmacological effects of 8 mg/kg MPH that the mice experienced during the sensitization phase may have simply been too different compared with those experienced during discrimination training, when 2 mg/kg MPH was administered to influence acquisition. Some evidence for this possibility was found in the generalization phase of the current study when 6 mg/kg MPH was tested and the mice nearly universally pressed on the vehicle-paired lever rather than the MPH-paired lever maintained on the 4 mg/kg training dose.
Finally, it is worth considering that a different discrimination task may have yielded a different outcome. For example, the previous work of McKim (1976) with scopolamine used a task that required rats to avoid a potent shock (0.5 mA), which is quite relevant to the test subject and therefore quickly learned. The demonstration that pre-exposure to scopolamine enhanced acquisition of this task suggests that drug exposure outside the training context could exert an influence on the discriminative stimulus control of reinforced behavior when the reinforcer (e.g. shock avoidance) has immediate salience to the test subject. Alternatively, rather than using a procedure that relies on negative reinforcement, another strategy might be to use the discriminative stimulus of MPH as an occasion setter predicting when a discrete cue signals delivery (or not) of a reinforcer such as sucrose. Such Pavlovian conditioning procedures can be rapidly trained and have been shown for drugs like alcohol (Besheer et al., 2012) and nicotine (Besheer et al., 2004; Palmatier et al., 2004) . Strategies like these may prove useful in future studies that examine the influence of drug exposure outside of the training context on the discriminative stimulus control of reinforced behavior by abused drugs.
Conclusion
The data presented here indicate that a locomotorsensitizing regimen of MPH in B6 mice does not enhance the acquisition of an MPH discrimination task, nor does it result in a left shift of the discrimination response function. The disconnect between MPH locomotor sensitization and discrimination in a classic operant task may be related to the differential pharmacological effects on monoaminergic neurotransmission between cortical and subcortical brain regions, and the role they play in supporting discriminative stimulus control of behavior.
